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Abstract
Background: Poststroke fatigue is a persistent and distressing symptom among stroke survivors. In this study, we
investigated the reliability and validity of a vertical numerical rating scale supplemented with a faces rating scale
(NRS-FRS) in measuring poststroke fatigue.
Methods: The fatigue intensity of 106 individuals with stroke was measured twice, 1 week apart, using a vertical
NRS-FRS to measure test-retest reliability. The intraclass correlation coefficient, a relative reliability index, was calculated to
examine the degree of consistency and agreement between the two test occasions. Absolute reliability indices, including
the standard error of measurement, minimal detectable change, and Bland-Altman limits of agreement, were used to
quantify measurement errors and determine systematic biases of the two test occasions. We also administered the
vertical NRS concurrently as a comparator measure for assessing fatigue in 50 consecutive patients with stroke who
were recruited later in the study period. The Spearman rank correlation coefficient (ρ) was used to examine the
concurrent validity of the NRS-FRS. Discriminant validity was assessed by means of receiver operating characteristic
curves, sensitivity, and specificity.
Results: The intraclass correlation coefficient was 0.95 for the NRS-FRS. The standard error of measurement and the
minimal detectable change at the 95 % confidence interval of the NRS-FRS were 0.50 and 1.39, respectively. The
Bland-Altman analyses showed no significant systematic bias between the repeated measurements. A narrow range
of the limits of agreement was shown on the Bland-Altman plot, indicating the NRS-FRS had high stability and
low variation between the two test occasions. The correlations between the NRS-FRS and NRS were good at test
(ρ = 0.85) and retest (ρ = 0.84). Compared with the NRS cutoff value of ≥1, sensitivity with the NRS-FRS at test and
retest was 94 and 92 % and specificity was 79 and 90 %, respectively.
Conclusions: This study provides further evidence of the reliability and validity of the NRS-FRS in measuring fatigue
intensity in patients with stroke. The NRS-FRS had high sensitivity and specificity. The NRS-FRS may be a reliable and
valid measure for clinicians and researchers to assess fatigue and determine whether a real change has occurred in
groups and at the individual level of patients with stroke.
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Introduction
Poststroke fatigue is a persistent and distressing symp-
tom among stroke survivors [1, 2], with a prevalence
ranging from 38 to 77 % [3, 4]. Fatigue often impedes
rehabilitation [5] and has serious effects on a sense of
not being in control [6], a higher risk of suicide [7], in-
creased mortality [3], increased energy cost for gait defi-
cits [8], and reduced physical fitness [9]. The recognition
of poststroke fatigue has driven the need of researchers
and clinicians for a valid, reproducible, and feasible
measurement for the screening and diagnosis of fatigue.
Fatigue after stroke is a multifaceted phenomenon as-
sociated with demographic, physiological, psychocogni-
tive, and organic factors [2, 5, 10]. The multidimensional
nature of fatigue creates difficulties for clinicians and re-
searchers in assessing the patient’s condition and imple-
menting the best treatment. Fatigue consists of acute
and chronic fatigue [9, 11, 12]. Acute fatigue is perceived
as fatigability (exertional fatigue), which develops after
certain activity, can be alleviated by rest, and is associ-
ated with neurologic impairment. Alternatively, chronic
fatigue is a state of weariness, which is unrelated to
activity or exertion, cannot be relieved after rest, and is
associated with prolonged stress or illness. Thus, post-
stroke fatigue has been defined as having components of
physical, cognitive, and social fatigue, which may vary by
individuals [2]. Although poststroke fatigue has mental
and psychological aspects as well as a physical basis [1],
physical fatigue is much greater influence in patients’ ex-
perience of fatigue and interfered with their daily activ-
ities [13].
Measuring fatigue remains an ongoing challenge for
clinical trials of fatigue management in stroke, because
no gold standard measure is available for poststroke fa-
tigue [3, 14–16]. Poststroke fatigue has been viewed as
difficult to measure adequately and is thus neglected as
a consequence [1, 12]. The assessment of fatigue must
consider the feasibility of a measure and individual’s
ability to successfully complete the measurement, which
may depend on the severity of fatigue and cognitive, vis-
ual, or language deficiencies of stoke patients. The meas-
urement for fatigue should be feasible with regard to
being simple to administer, easy to score, and completed
with minimal time and effort, for not adding fatigue in-
tensity [17]. In this regard, single-item measure of fa-
tigue intensity, such as the visual analog scale (VAS) [9,
12, 17, 18] and numerical rating scale (NRS) [19, 20],
seem to be more advantageous than multiple-item mea-
sures [21]. For people experiencing severe fatigue, multi-
dimensional fatigue measures may increase the burden
of responding [22]. Stroke patients may have problems
recalling their fatigue levels of prior week, which might
affect the accuracy of the data [11]. Some people with
right hemispheric stroke might present hemineglect to
their left side [23]; other people with left hemispheric
stroke might have difficulty in fully understanding an in-
struction [24]. Yet, the VAS is not recommended for
geriatric patients [25] or stroke patients with cognitive
or visuospatial impairments [23].
Alternatively, the NRS is commonly used to estimate
fatigue intensity in individuals with stroke [19], multiple
sclerosis [21], spinal cord injury [26], fibromyalgia [27], and
cancer [28]. Previous studies have demonstrated that the
NRS is a valid, reliable, and highly responsive measure of
fatigue in patients with rheumatoid arthritis [29, 30] and
multiple sclerosis [21]. The NRS evaluates patient’s fatigue
level at a 0-to-10 scale. The chosen number signifies the
severity of subject’s fatigue, with 0 indicating no fatigue and
10 indicating the worst possible fatigue. The NRS is
extremely easy to administer and has shown good sensitiv-
ity, clinical relevance, and usefulness [19, 28, 29]. Therefore,
the NRS is a suitable instrument for stroke patients because
of validity, reliability, and preference. However, in consider-
ation of possible lacking cognitive and visuospatial
functions in stroke patients or elderly participants, an
adaptation of the NRS to assess fatigue may be needed.
The faces rating scale (FRS) has been successful in
measuring pain in cognitively impaired patients [24] and in
illiterate patients [31–33]. The 0–10 vertical NRS supple-
mented with the Wong-Baker FRS was reliable in measur-
ing pain after stroke [34]. Therefore, a vertical NRS scale
incorporating with the FRS would be an a priori preferable
measurement of poststroke fatigue. Hence, the 6-face
Wong-Baker FRS was used to make it comparable with the
NRS in scoring by use of a common metric (0–10) in the
present study. Our aim was to determine the test-retest
reliability and validity of the vertical NRS incorporated with




Stroke patients who were diagnosed between December
2013 and January 2015 were recruited at three medical cen-
ters. The inclusion criteria were (a) a first-ever stroke onset
of at least 3 months before recruitment, (b) enrollment in
an outpatient rehabilitation program, (c) ability to follow
study instructions and complete the scale (Mini-Mental
State Examination score of ≥22), and (d) no participation in
experimental rehabilitation or drug studies during the study
period. The local Institutional Review Board of Mackay
Memorial Hospital and Chang Gung Memorial Hospital
approved the study procedures, and all participants
provided written informed consent.
The exclusion criteria were (a) physician-determined
major medical problems, (b) inability to complete ques-
tionnaires or study outcome measures because of severe
cognitive impairment, neglect, or attention deficits, and
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(c) irregular use of medications for fatigue or other
fatigue-relieving treatment during the study period.
Procedure
Eligible patients who received outpatient rehabilitation
were invited to participate. For determining test-retest
reliability of the scale, NRS-FRS was assessed twice with
a 1-week interval to reduce the memory effect of the
first assessment, and at the same time of day to
minimize diurnal variation in fatigue. Test and retest as-
sessments were administered by the same research as-
sistant. In addition, 50 consecutive participants were
asked to indicate the severity of their fatigue successively
on the NRS-FRS and the vertical NRS. The vertical NRS
was used as a comparator measure to test the concur-
rent validity of NRS-FRS.
Outcome measure of fatigue
Fatigue was defined as a feeling of physical tiredness and
lack of energy [35], as assessed using the NRS-FRS and
the vertical NRS. Participants were provided a full
explanation of the fatigue measures and received in-
structions on how to complete the scales. To facilitate
scoring the intensity of participants’ fatigue, the NRS-
FRS was a combination of the vertical NRS with word
anchors on a scale of 0 to10 and the 6 facial expressions
of Wong-Baker FRS (Fig. 1).
A 10-cm vertical line anchored by a smiling face with
the bottom number 0 to indicate “no fatigue” and a
crying face with the top number 10 to indicate “worst
possible fatigue.” Participants were asked to point only
to a number, not a face, on the NRS-FRS that best repre-
sented their present level of fatigue (“How fatigued do
you currently feel?”) using the 10-point single-item
fatigue scale (0 = “no fatigue” and 10 = “worst possible
fatigue”). Fatigue severity units included none, 0; mild,
1 to 3; moderate, 4 to 6; and severe, 7 to 10, giving it
ordinal properties of measurement [29]. The higher the
NRS-FRS score, the higher the fatigue. The 10-point
fatigue scale is well validated to assess fatigue in people
with cancer [28].
Data analysis
The relative reliability of the NRS-FRS was determined
through intraclass correlation coefficient (ICC) using a
2-way mixed-effect model with an agreement coefficient
[36]. ICCs that exceed 0.75 indicate good reliability [37].
We used the standard error of measurement (SEM), the
minimal detectable change (MDC), and Bland-Altman
analyses to quantify the absolute reliability.
The SEM indicates within-subject variability in re-
peated measures for a group of individuals [38]. The
MDC95 is the smallest change necessary to exceed the
measurement error of repeated measures that indicates a
real change at the 95 % confidence interval (CI) level for
a single individual [38, 39]. Bland-Altman analyses were
used to indicate systematic bias between repeated mea-
surements [40]. The Bland-Altman plot illustrates the
agreement between the two test occasions (time 1 and
time 2) and identifies possible outliers. The 95 % CI of
the mean difference was used to determine systematic
bias. If zero is included within the 95 % CI, no signifi-
cant systematic bias between measurements can be in-
ferred [40]. The 95 % limits of agreement (LOA) were
used to examine the natural variation over time, with a
narrow LOA indicating higher stability [41].
We studied concurrent validity to validate the NRS-
FRS with the NRS obtained concurrently in a subsample
of participants at 2 study visits [37]. The Spearman rank
correlation coefficient (ρ) was used to examine the rela-
tion between the NRS-FRS and NRS at test and retest.
We used the following criteria to interpret the magni-
tude of the correlation coefficients: <0.25 indicating low
correlations, 0.25 to 0.5 indicating fair correlations, 0.5
to 0.75 indicating moderate-to-good correlations, and >0.75
indicating good-to-excellent correlations [37]. Discriminant
validity was assessed by means of receiver operating charac-
teristic (ROC) curves, sensitivity, and specificity. ROC ana-
lysis was used to define the best NRS-FRS cutoff score of
the 50 participants. ROC curves were plotted to determine
Fig. 1 Numerical rating scale supplemented with a faces rating scale
for self-reported fatigue intensity
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the area under the curve (AUC), which represents the abil-
ity of the NRS-FRS to discriminate between those with and
without fatigue [37]. The sensitivity and specificity of the
NRS-FRS were calculated using the cutoff point ≥1 and
were represented by ROC curves.
Results
The 106 participants were a mean age of 53.63 years,
and the average time after stroke onset was 24.40 months
(Table 1). The detailed characteristics of the participants
and the descriptive statistics for the NRS-FRS in the two
test occasions are reported in Table 1.
As detailed in Table 2, the ICC for the NRS-FRS was
0.95 (95 % CI, 0.92–0.96), indicating good relative reli-
ability of the NRS-FRS. The SEM and MDC95 of the
NRS-FRS were 0.50 and 1.39, respectively. The mean
difference between the test-retest measures of the NRS-
FRS was close to 0 (−0.16). The 95 % CI for the mean
difference included 0 (−0.36 to 0.04), demonstrating that
there was no significant systematic bias between test-
retest measures in poststroke fatigue. The Bland-Altman
plot (Fig. 2) that was representative of the NRS-FRS
showed the variability between the test-retest measures.
The repeatability for most of the test-retest measures
was within the 95 % CI. The LOA range was −2.12 to
1.80, and 4 outliers are shown on the plot.
The correlations between the NRS-FRS and NRS were
good at test (ρ = 0.85) and retest (ρ = 0.84), as reported
in Table 3. Compared with the criterion measure of the
NRS, the sensitivity of NRS-FRS ≥1 for fatigued patients
at test and retest was 94 and 92 % and specificity was 79
and 90 %, respectively (Table 4). ROC curves of fatigued
(NRS ≥1) and not fatigued (NRS <1) with the NRS-FRS
at test and retest are shown in Fig. 3. The AUC was
0.948 (95 % CI, 0.89–1.00) for test and 0.931 (95 % CI,
0.85–1.00) for retest.
Discussion
This study provides evidence of the test-retest reliability
and validity of the vertical NRS-FRS in quantifying the
intensity of fatigue in individuals with stroke. The rela-
tive and absolute reliability of the NRS-FRS showed
good test-retest reliability, with high agreement, small
measurement error, and no systematic bias for the as-
sessment of poststroke fatigue. The concurrent validity
of the NRS-FRS was good. The sensitivity and specificity
of the NRS-FRS were high. These findings suggest that
the vertical NRS-FRS may be a reliable and valid instru-
ment to assess poststroke fatigue. Moreover, measuring fa-
tigue provides additional information that is essential to
understand disease outcome from the patient’s perspective.
Limited empirical evidence about the reliability of in-
struments for measuring poststroke fatigue has seriously
hampered efforts to synthesize common knowledge
about fatigue. Establishing the reliability of a tool for the
adequate assessment of fatigue is an important pre-
requisite before the tool is adopted as a standard meas-
ure of poststroke fatigue. Test-retest reliability is the
ability of an outcome measure to capture similar scores
on 2 separate occasions of test administration, given that
the patient’s condition has not changed [37]. The ICC
gives a measure of consistency or agreement of values
within cases [42]. The ICC value in this study (0.95) in-
dicated a high degree of agreement between the test-
retest measures and good reproducibility of the vertical
NRS-FRS. Our data were in line with values reported in
previous studies, which indicated good reliability of the
NRS in patients with multiple sclerosis (ICC = 0.97) [21]
and rheumatoid arthritis (ICC = 0.79) [29].
Determination of the absolute reliability of measures is
critical to ensure repeated measurements with satisfac-
tory stability and sensitivity to real changes over time
Table 1 Characteristics of the Participants (n = 106)
Characteristic No (%), mean (SD), or
median (range)
Sex
Male 77 (72.6 %)
Female 29 (27.4 %)
Age, year 53.63 (11.25)
Localization
Right hemisphere 48 (45.3 %)
Left hemisphere 58 (54.7 %)
Interval after stroke onset, months 24.40 (24.11)
Brunnstrom stage of upper limb
Proximal part 4 (1–6)
Distal part 3 (1–6)
Brunnstrom stage of lower limb 4 (3–5)
Fugl-Meyer Assessment of upper limb 33.74 (17.62)
Fugl-Meyer Assessment of lower limb 21.18 (6.94)
First assessment of fatigue intensity with
NRS-FRS
1.93 (2.30)
Patients with severe fatigue of 7–10 4 (3.8 %)
Patients with moderate fatigue of 4–6 20 (18.9 %)
Patients with mild fatigue of 1–3 40 (37.7 %)
Patients with no fatigue 42 (39.6 %)
Second assessment of fatigue intensity
with NRS-FRS
1.77 (2.21)
Patients with severe fatigue of 7–10 4 (3.8 %)
Patients with moderate fatigue of 4–6 16 (15.1 %)
Patients with mild fatigue of 1–3 42 (39.6 %)
Patients with no fatigue 44 (41.5 %)
Mini Mental State Exam scores 27.56 (2.43)
Abbreviation: SD standard deviation, NRS-FRS numerical rating scale
supplemented with faces rating scale
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[43]. Reliable outcome measures demonstrate small
measurement errors for a group of patients and small
true changes for an individual patient. The SEM and
MDC95 of the test-retest measures provide the absolute
values of the measurement errors between repeated
measures and determine whether changes in repeated
measures for a group and for an individual are real, re-
spectively [44, 45]. From the result of the MDC95 of the
NRS-FRS, if the change in repeated measures of the
NRS-FRS for a stroke patient was more than 1.39, then
the change was interpreted as a real change or a true
change beyond measurement error at the 95 % CI. The
SEM and MDC95 of the NRS-FRS were similar to those
in a previous study of the Fatigue Severity Scale (FSS)
for measuring fatigue in polio survivors (SEM = 0.56,
MDC95 = 1.55) [46] despite different patient populations
and outcome measures.
Limited studies have presented the test-retest reliabil-
ity of the fatigue scales by the Bland-Altman method
[16, 29]. In the present study, the Bland-Altman statis-
tics for the NRS-FRS in individuals with stroke indicated
no significant systematic bias and narrow LOA between
the repeated measures. These results were similar to the
use of the NRS in measuring fatigue in rheumatoid
arthritis [29], the Fatigue Assessment Scale in evaluating
fatigue after stroke [16], and the NRS-FRS in measuring
Table 2 Relative and absolute reliabilities of a numerical rating scale supplemented with a faces rating scale
Scale ICC (95 % CI) SEM MDC95 Bland-Altman analysis
d SDdiff SE of d 95 % CI of the d LOA
NRS-FRS 0.95 (0.92–0.96) 0.50 1.39 −0.16 1.00 0.10 −0.36 to 0.04 −2.12 to 1.80
NRS-FRS numerical rating scale supplemented with faces rating scale, ICC intraclass correlation coefficient, CI confidence interval, SEM standard error of
measurement = SDpooled × √(1 − ICC)], where SDpooled is the standard deviation for all observations from test occasions 1 and 2, MDC95 minimal detectable change
at the 95 % CI level = 1.96 × √2 × SEM = 1.96 × √2 × SDpooled × √(1 − ICC)], where 1.96 is the 2-tailed tabled z value for the 95 % CI and √2 represents the variance of
2 measures, d mean of difference between the two test sessions (test session 2 minus test session 1), SDdiff standard deviation of mean difference, SE standard
error, 95 % CI of the d mean difference ± 1.96 × SE = d ± 1.96 × (SDdiff /√n), where n is the sample size, 95 % LOA 95 % limits of agreement = d ± 1.96 SDdiff
Fig. 2 Bland-Altman plot for the test-retest reliability. The plot illustrates the agreement between time 1 and time 2 and identifies possible outliers. Each
sample is represented on the graph by conveying the mean value of the 2 assessments (x-axis) and the difference between the 2 assessments (y-axis).
The mean difference was the estimated bias, and the standard deviation (SD) of the differences measured the fluctuations around this mean (outliers being
above 1.96 SDdiff). Reference lines shows mean difference between time 1 and time 2 (solid line), and 95 % limits of agreement for the mean difference
(broken lines)
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pain after stroke [34]. The Bland-Altman plots for
test-retest reliability of the NRS in rheumatoid arthritis
demonstrated small differences on repeated measure-
ment and no bias in the distribution [29]. Test-retest
agreement for the Fatigue Assessment Scale in stroke
individuals had the narrowest LOA, and the mean dif-
ference between test and retest measurements was not
significant [16]. Generally, this study found that the
absolute reliability of the NRS-FRS in assessing post-
stroke fatigue is good, with no bias in the distribution
and small differences on repeated measurement. The
mean difference between the two testing occasions
was close to zero, and the 95 % CI of the mean differ-
ence included zero. From the Bland-Altman plot, the
narrow range of the LOA and the 4 outliers in the
NRS-FRS indicated a high stability and less natural
variation over time.
The diagnostic value of the NRS-FRS to assess fa-
tigue in stroke patients was also analyzed by compar-
ing to NRS. The correlations between the NRS-FRS
and NRS is high, fluctuating only slightly at test
(ρ = 0.85) and retest (ρ = 0.84). This suggested that the
relationships between the tests are relatively stable
over a 1-week interval, which reflects constant and
true relationships between the tests and indicates that
both measure the same construct. The NRS has been
validated for assessing fatigue severity in patients with
ankylosing spondylitis [47] and rheumatoid arthritis
[30]. Despite the differences in sample characteristics,
the findings of our study are consistent with results of
prior research in supporting the NRS and NRS-FRS as
being valid measures for fatigue intensity. When the
NRS-FRS is used to distinguish fatigue from no fa-
tigue, the area under the ROC curve is very high at
test (AUC = 0.948) and retest AUC = 0.931). These re-
sults highly suggest that the NRS-FRS is an appropri-
ate tool for the assessment of physical fatigue in
stroke patients.
Despite high correlation and AUC, higher cut-off
values of the NRS-FRS might be insufficiently accurate
to guide fatigue management. For example, when
NRS-FRS cutoff value was set ≥1 for detecting fatigue
at the first assessment, 6 % of the patients with no fa-
tigue would be incorrectly classified as having fatigue,
and 21 % of patients with fatigue would be incorrectly
classified as no fatigue. If the cutoff point was in-
creased to >5, 11 % of stroke patients with no fatigue
would be incorrectly classified as having fatigue, and
12 % with fatigue would be classified as having no
fatigue.
Most fatigue studies in stroke rely on questionnaires,
such as FSS [10, 48, 49], Multidimensional Fatigue
Symptom Inventory (MFSI) [16], VAS [9, 12, 17, 18],
and NRS [19, 20]. The FSS and MFSI are validated
measures for fatigue, but both rely on retrospective re-
call of fatigue during the preceding 1 week rather than
a real-time assessment. In contrast, VAS and NRS are
single-item measures of self-reported fatigue severity
that prospectively capture real-time fatigue. Thus,
VAS and NRS did not have recall bias and respondent
burden is low [21]. Actually, the VAS has been shown
to be a reliable and valid instrument for the quantita-
tive assessment of fatigue in healthy subjects [17], pa-
tients with sleep disorders [17], and people with
chronic stroke [12]. However, the VAS is influenced by
eye-hand coordination problems [11]. Patients with
paralysis, tremors, or visual impairment are unable to
complete the VAS reliably [17]. The application of
VAS is limited to the motor, cognitive, and visual abil-
ities of the subjects.
Patients with poststroke fatigue may have problems
completing long questionnaires. The feasibility of a fa-
tigue scale is frequently the element that determines
the initial choice of an instrument for individuals with
stroke. It should be short, easy to understand and an-
swer, have a minimal respondent burden, and be
Table 3 Concurrent validity (Spearman Rank Correlation
Coefficient) of the NRS-FRS and NRS at test and retest
Criterion measure Test Retest
NRS-FRS (95 % CI) NRS-FRS (95 % CI)
NRS 0.85* (0.75–0.91) 0.84* (0.73–0.91)
*P < 0.01
Table 4 Sensitivity and Specificity of the NRS-FRS at Test and Retest
Criterion measure Cut-off score Test NRS-FRS Retest NRS-FRS
Sensitivity, % Specificity, % AUC Sensitivity, % Specificity, % AUC
NRS 1 94 79 0.948 92 90 0.931
2 97 79 0.913 85 75 0.900
3 96 75 0.907 77 89 0.910
4 94 82 0.921 73 79 0.859
5 89 88 0.959 56 90 0.871
AUC Area under the curve
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reliable when replicated [17]. Fatigue intensity is prob-
ably the easiest and simplest dimension of fatigue to
assess and a reasonable way to begin the discussion
about fatigue. All participants in this study were able
to complete the NRS-FRS. The reliability and validity
results of this study showed that a simple approach of
combining the NRS with the FRS created a reliable
and valid tool for assessing poststroke fatigue. The
NRS-FRS is easy to understand, quick to complete,
simple to score, and does not place an excessive burden on
patients. In the absence of fully validated gold standards,
the vertical NRS-FRS, with good test-retest reliability and
validity, could be used to monitor real-time fatigue, facili-
tate faster communication between patients and clinicians
regarding their fatigue experience and response to treat-
ment, and allow for future comparability across different
studies. Since fatigue levels may fluctuate throughout the
day [21] and exertional fatigue may be perceived after activ-
ities [9], it is important to administer the NRS-FRS at the
same time of day and to avoid administering it after phys-
ical and cognitive activity.
However, we acknowledge that the one-dimensional
measurement may have value as a screening tool for
documentation but not fully interpret the intricacies of
the symptom and may not address the linkage between
fatigue intensity and functional limitations [9, 26]. Post-
stroke fatigue was predominantly physical rather than
mental [13, 35]. Chalder et al. recommended that fatigue
severity be accompanied by an assessment of fatigue
interference with activities, which may offer a more
thorough description of the fatigue experience, capture
the most salient issues, and trigger a comprehensive list
of problems [50]. In future studies, we propose a positive
screening of the NRS-FRS should be followed up with a
more comprehensive assessment of patients’ perceptions
of functional impairment and interference due to fatigue,
in addition to single-symptom questions measuring fa-
tigue intensity, to facilitate a more complete description
of the fatigue experience in daily life for individuals with
stroke.
A good example of a more comprehensive instrument
is the Brief Fatigue Inventory (BFI), which was devel-
oped to assess the severity of fatigue and the effect of
fatigue on daily functioning in the past 24 h for patients
with cancer [51]. The BFI has 9 items, and each item is
rated on an 11-point NRS. The BFI might be an optimal
outcome measurement between multidimensional
fatigue measures and a single-item measurement to
reveal a tremendous amount about an individual’s
fatigue status. Future study might consider investigating
the psychometric properties of the BFI in individuals
with stroke.
Some limitations of our study warrant consideration.
First, all participants in the present study completed
the NRS-FRS at two assessments, with a 1-week inter-
val, at the same time of day to minimize any diurnal
variation in fatigue. Fatigue was measured as a single
time-point assessment; that is, current fatigue inten-
sity, which might not reflect overall fatigue on the
testing day. Future studies may consider measuring fa-
tigue at different times of the day to facilitate a better
understanding of daily fluctuations in poststroke fa-
tigue and to improve the psychometric properties of
the NRS-FRS.
Second, future studies need to identify predictors of
poststroke fatigue to address fatigue issues with an
intervention in people with stroke. To explore the ef-
fectiveness of an intervention to manage fatigue or the
progression of fatigue, the ability of the NRS-FRS to
detect change over time requires further development.
In conclusion, our research shows that the vertical
NRS-FRS has good test-retest reliability and validity in
measuring physical fatigue after stroke, with good agree-
ment, low measurement error, and high sensitivity and
specificity.
Fig. 3 Receiver operating characteristic (ROC) curves of the numerical
rating scale-faces rating scale (NRS-FRS) at (a) test and (b) retest (NRS
cutoff point of 1 as a criterion measure). The area under the curve (AUC)
was 0.948 for test and 0.931 for retest
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